Our efforts to use GFAP as COA showed that GFAP was not entirely useful in distinguishing the different subgroups of PMS patients, with the exception of separating cluster “G” from patients with a more sever phenotype (clusters “O” and “R”). The gene discussed is GFAP; the disease is premenstrual tension.